Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

DNASTAR Releases NovaFoldTM Structure Prediction Software

Published: Wednesday, July 24, 2013
Last Updated: Wednesday, July 24, 2013
Bookmark and Share
DNASTAR® announces the release of NovaFoldTM, to complement its existing DNA, RNA and protein sequence and structure analysis software product line.

NovaFold is based on the I-TASSER algorithms developed at the University of Michigan by Dr. Yang Zhang and his team of scientists.   I-TASSER has won the biennial Critical Assessment of protein Structure Prediction (CASP) competition for the past eight years.  As such, it is recognized as the premier sequence-based protein structure prediction software globally.

NovaFold combines  the award-winning I-TASSER algorithms with key components from DNASTAR’s long history of successful software development and commercialization, including an intuitive graphical user interface; integration with Protean 3D, which is the protein sequence, structure and bioinformatic analysis component of DNASTAR’s Lasergene software; and use of the Amazon cloud, supplementing DNASTAR’s other software on the cloud,  released earlier this year.

Tom Schwei, Vice President and General Manager of DNASTAR, said, “NovaFold is the result of hard work by many people both within and outside of DNASTAR.  This is a major step forward in DNASTAR’s collaboration with a recognized global leader in this domain and NovaFold represents a significant broadening of DNASTAR’s product offering.  NovaFold will appeal to many of our current customers as well as attract structural biologists and protein scientists whose work didn’t previously give them exposure to DNASTAR software products.   It also represents an ideal use of the Amazon cloud, which we have incorporated into the product design to handle the most complex, time consuming calculations, while delivering results quickly and effectively to Protean 3D software on the cloud or on a scientist’s desktop computer.   We are very pleased with this initial release of NovaFold and we look forward to continuing to improve it in the future.”

Dr. Yang Zhang added, “I am very excited to see DNASTAR advance the work of our team for greater commercial exposure.  I-TASSER has long had a strong presence in the academic market.  DNASTAR’s advances and improvements on the technology will help open up new markets supporting a wider range of scientists, which will eventually help advance our understanding of the fundamental relation between sequence, structure and function of protein molecules.  I have enjoyed working with DNASTAR and look forward to continuing to collaborate with their scientists towards future technical improvements in the product, as well.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Inhibrx Adopts DNASTAR Lasergene Software
Company has announced that the Inhibrx has entered into an agreement supporting an organization-wide site license of DNASTAR Lasergene software.
Wednesday, March 30, 2016
DNASTAR Appoints Pure Health Medical Supplies
Company appoints Purehealth as distributor of molecular biology software in the Middle East.
Thursday, September 24, 2015
DNASTAR Appoints Biotech Del Norte Mexico as Distributor
Biotech del Norte distributes Company’s DNA, RNA and protein sequence analysis software in Mexico.
Wednesday, August 05, 2015
DNASTAR Appoints Tom Lynch Vice President of Sales
Dr. Lynch played key roles in the successful launch of Aldevron’s recombinant protein business.
Wednesday, January 21, 2015
DNASTAR Awarded Antibody Engineering Software SBIR Grant
Company receives Phase II SBIR grant award from the National Institutes of Health.
Tuesday, September 16, 2014
DNASTAR Awarded Structural Biology Software SBIR Grant
Company receives Phase I SBIR grant award from the National Institutes of Health.
Wednesday, June 11, 2014
Wellcome Trust Sanger Institute Adopts DNASTAR Lasergene Software
Wellcome Trust Sanger Institute and DNASTAR have entered into a multi-year software license agreement.
Thursday, December 05, 2013
DMNB Adopts DNASTAR Lasergene Software
New Lasergene software site license agreement for genome sequence assembly and analysis.
Thursday, September 05, 2013
Dalhousie Medicine New Brunswick Adopts DNASTAR Lasergene Software
DMNB has entered into an agreement supporting an enterprise-wide site license of DNASTAR Lasergene software for genome sequence assembly and analysis.
Thursday, September 05, 2013
Eppley Institute Adopts DNASTAR Software
New site license of DNASTAR Lasergene software for use in sequence assembly and analysis.
Thursday, July 04, 2013
DNASTAR Awarded Fast-Track Phase I and Phase II SBIR Grant
Company receives grant award from NIH to support the development of software for clinical research.
Wednesday, September 26, 2012
DNASTAR Awarded Antibody Engineering SBIR Grant
NIH awarded grant to build antibody engineering software.
Tuesday, May 15, 2012
DNASTAR Partners with Ion Torrent
Ion Torrent offers DNASTAR’s sequence assembly and analysis software products to the customers through the Ion Torrent on-line web store in the collaboration.
Wednesday, February 16, 2011
DNASTAR Software Grant Supports Ion Torrent Awards
Firm will provide licenses of its next-gen sequencing suite of software tools to the two European winners of the extension of the grant program.
Monday, June 14, 2010
DNASTAR Joins BioIT Alliance
BioIT Alliance announces the expansion of the BioIT Alliance program to include DNASTAR.
Thursday, January 28, 2010
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
NIH Study Determines Key Differences between Allergic and Non-Allergic Dust Mite Proteins
Researchers at NIH have uncovered factors that lead to the development of dust mite allergy and assist in the design of better allergy therapies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos